Camlin Fine Sciences informs about revised earnings presentation

31 May 2021 Evaluate

In continuation to its intimation dated May 30, 2021 in relation to the conference call with various domestic and  international  investors  and  analysts  to  discuss  the  financial  results  of  the  Company for the quarter and financial year ended March 31, 2021 (Q4) on May 31, 2021, Camlin Fine Sciences has informed that it has enclosed the revised earnings presentation made for the aforesaid call. The company has clarified that the presentation and the information contained therein does not constitute or form  part of an invitation or solicitation to offer to purchase or subscribe to any securities of the Company  in  any  jurisdiction.  This presentation has  been  prepared  for  information  purposes  only. The  information contained in the earnings presentation is not to be taken as any recommendation made  by the Company or any other person to enter into any agreement with regard to any investment. Take  this on the records and the  same  be treated  as  compliance  under  the  applicable Regulations of SEBI LODR.

The above information is a part of company’s filings submitted to BSE.



Camlin Fine Sciences Share Price

119.95 0.80 (0.67%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1069.40
SRF 2165.85
Pidilite Inds. 2958.60
Aarti Inds 430.80
Atul 7261.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.